Women with diabetes mellitus are at high risk of myocardial infarction (MI), and it is well recognized that smoking, hypertension, hyperlipidaemia and the diabetic state itself do not fully explain this increased risk. During the last decade, growing evidence has accumulated that the immune system, with oxidized low-density lipoprotein (LDL) as a key antigen, plays an important role in the development of atherosclerosis. The aim of the present study was to explore the association between the immune response, as measured by antibody titres to malondialdehyde-treated LDL (MDA-LDL) and levels of C-reactive protein (CRP; a marker of inflammation), and diabetes mellitus and MI in women. Women (35-64 years) with diabetes (n = 18) and non-diabetic women (n = 46) who had been treated in hospital for MI were compared with diabetic women without MI (n = 35) and healthy controls (n = 70). Blood samples were collected after an overnight fast. CRP was determined with a highly sensitive immuno-enzymometric assay. IgM and IgG antibodies against MDA-LDL were analysed with a solid-phase ELISA technique. Women with diabetes but without previous MI were more similar to women with previous MI (both with and without diabetes) than to the healthy controls. Compared with healthy women, the women with diabetes and/or MI had higher IgG (P < 0.05) and lower IgM (P = 0.006) antibody titres against oxidized LDL and higher CRP levels (P < 0.001), associations that were independent of other cardiovascular risk factors. These findings might indicate a differentiated immune response against modified LDL, more pronounced inflammation and a more aggressive atherosclerotic process in women with diabetes.
Skip Nav Destination
Article navigation
Research Article|
October 03 2001
Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women
Annika DOTEVALL;
Annika DOTEVALL
*Section of Preventive Cardiology, Department of Medicine, SU/Östra, Sahlgrenska University Hospital, Göteborg University, S-413 45 Göteborg, Sweden
Search for other works by this author on:
Johannes HULTHE;
†Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, S-413 45 Göteborg, Sweden
Correspondence: Dr Johannes Hulthe (e-mail [email protected]).
Search for other works by this author on:
Annika ROSENGREN;
Annika ROSENGREN
*Section of Preventive Cardiology, Department of Medicine, SU/Östra, Sahlgrenska University Hospital, Göteborg University, S-413 45 Göteborg, Sweden
Search for other works by this author on:
Olov WIKLUND;
Olov WIKLUND
†Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, S-413 45 Göteborg, Sweden
Search for other works by this author on:
Lars WILHELMSEN
Lars WILHELMSEN
*Section of Preventive Cardiology, Department of Medicine, SU/Östra, Sahlgrenska University Hospital, Göteborg University, S-413 45 Göteborg, Sweden
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
March 23 2001
Revision Received:
May 22 2001
Accepted:
July 13 2001
Online ISSN: 1470-8736
Print ISSN: 0143-5221
The Biochemical Society and the Medical Research Society © 2001
2001
Clin Sci (Lond) (2001) 101 (5): 523–531.
Article history
Received:
March 23 2001
Revision Received:
May 22 2001
Accepted:
July 13 2001
Citation
Annika DOTEVALL, Johannes HULTHE, Annika ROSENGREN, Olov WIKLUND, Lars WILHELMSEN; Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women. Clin Sci (Lond) 1 November 2001; 101 (5): 523–531. doi: https://doi.org/10.1042/cs1010523
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |